Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Neuravi, a company out of Galway, Ireland, won the European CE Mark for its EmboTrap II Revascularization Device to treat acute ischemic stroke. The device is made to trap clots, deliver TICI 2b-3 reperfusion, and consistently grab onto the clot as it's removed from the patient.
Based on the original EmboTrap that came to market in Europe last year, the new device is intended to treat a greater range of clot lengths via a .021″ microcatheter.
"The EmboTrap platform has been a great addition to my clinical practice. In my first nine cases using the device, I was able to get TICI 2b-3 reperfusion in one pass. Now with the EmboTrap II, I've had comparably good results when treating longer occlusions," said Christian Taschner, M.D., professor of Radiology, University of Freiburg, Germany, in a press release. "In fact, in early evaluations of the EmboTrap II 5×33 at six centers, 16 of 17 cases resulted in TICI 2b-3 flow. The open design of the device helps trap clot inside and also makes it quite flexible, which is important when removing clot from the arteries of the brain."
Product page: emboTrap II…
Press release: Neuravi…
This post EmboTrap II Clot Retriever for Acute Ischemic Stroke Cleared in Europe appeared first on Medgadget.
The short ACTH stimulation test (250μg) is the dynamic test most frequently used to assess adrenal function. It is possible that a single basal cortisol could be used to predict the dynamic response, but research has been hampered by the use of different assays and thresholds.
To propose a morning baseline cortisol criterion of three of the most commonly-used modern cortisol immunoassays - Advia Centaur (Siemens), Architect (Abbott) and the Roche Modular System (Roche) - that could predict adrenal sufficiency.
Observational, retrospective cross-sectional study at two centres.
Retrospective analysis of the results of 1019 SSTs with the Advia Centaur, 449 SSTs with the Architect, and 2050 SSTs with the Roche Modular System assay. Serum cortisol levels were measured prior to injection of 250μg Synacthen and after 30 minutes. Overall, we were able to collate data from a total of 3518 SSTs in 3571 patients.
Using receiver-operator curve analysis, baseline cortisol levels for predicting passing the SST with 100% specificity were 358 nmol/l for Siemens, 336 nmol/l for Abbott and 506 nmol/l for Roche. Utilising these criteria: 589, 158 and 578 SSTs respectively for Siemens, Abbott and Roche immunoassays could have been avoided.
We have defined assay-specific morning cortisol levels that are able to predict the integrity of the hypothalamo-pituitary-adrenal axis. We propose that this represents a valid tool for the initial assessment of adrenal function and has the potential to obviate the need for dynamic testing in a significant number of patients.
This article is protected by copyright. All rights reserved.
Congenital hypogonadotropic hypogonadism (CHH) with either normal olfaction or anosmia (Kallmann syndrome (KS)) is a cause of pubertal failure secondary to pituitary gonadotropin deficiency. It appears during fetal life and persists throughout the postnatal, pre- and post-pubertal periods (1). For many years KS was considered to be a genetic disorder in which CHH persists throughout life, but case series of KS/CHH reported over the past 15 years show that gonadotropin and testicular functions can recover spontaneously, partially or completely (2,3).
This article is protected by copyright. All rights reserved.
The aim of this study was to assess the presence of herpesviruses and periodontopathic bacteria and to establish their potential association with pericoronitis.
Fifty samples obtained with paper points (30 from pericoronitis and 20 controls) were subjected to polymerase chain reaction (PCR) analysis. A single-stage and nested PCR assays were used to detect herpesviruses: human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) and six periodontopathic anaerobic bacteria: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Parvimonas micra, Treponema denticola, and Tannarella forsythia.
Pericoronitis samples harbored HCMV and EBV at significantly higher rates than the control group (70 vs. 40 % and 46.7 vs. 15 %, P = 0.035, P = 0.021, respectively). P. micra and T. forsythia (66.7 vs. 0 %, and 40 vs. 10 %, P = 0.001, P = 0.021, respectively) were significantly more common in pericoronitis compared to the control group. Multivariate logistic regression analysis showed that the presence of T. forsythia was associated with pericoronitis development (OR 7.3, 95 % CI, 1.2–43.2, P = 0.028).
The occurrence of HCVM and EBV extends our previous knowledge on microbiota in pericoronitis. These PCR-based findings demonstrated that bacterial and viral DNA occurred concomitantly in pericoronitis samples. T. forsythia appeared to be significantly associated with pericoronitis development in the examined sample.
Herpesviral-bacterial co-infections might exacerbate the progression of pericoronitis.
The aim of this study was to assess the presence of herpesviruses and periodontopathic bacteria and to establish their potential association with pericoronitis.
Fifty samples obtained with paper points (30 from pericoronitis and 20 controls) were subjected to polymerase chain reaction (PCR) analysis. A single-stage and nested PCR assays were used to detect herpesviruses: human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) and six periodontopathic anaerobic bacteria: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Parvimonas micra, Treponema denticola, and Tannarella forsythia.
Pericoronitis samples harbored HCMV and EBV at significantly higher rates than the control group (70 vs. 40 % and 46.7 vs. 15 %, P = 0.035, P = 0.021, respectively). P. micra and T. forsythia (66.7 vs. 0 %, and 40 vs. 10 %, P = 0.001, P = 0.021, respectively) were significantly more common in pericoronitis compared to the control group. Multivariate logistic regression analysis showed that the presence of T. forsythia was associated with pericoronitis development (OR 7.3, 95 % CI, 1.2–43.2, P = 0.028).
The occurrence of HCVM and EBV extends our previous knowledge on microbiota in pericoronitis. These PCR-based findings demonstrated that bacterial and viral DNA occurred concomitantly in pericoronitis samples. T. forsythia appeared to be significantly associated with pericoronitis development in the examined sample.
Herpesviral-bacterial co-infections might exacerbate the progression of pericoronitis.
Neurons differentiated from pluripotent stem cells using established neural culture conditions often exhibit functional deficits. Recently, we have developed enhanced media which both synchronise the neurogenesis of pluripotent stem cell-derived neural progenitors and accelerate their functional maturation; together these media are termed SynaptoJuice. This pair of media are pro-synaptogenic and generate authentic, mature synaptic networks of connected forebrain neurons from a variety of induced pluripotent and embryonic stem cell lines. Such enhanced rate and extent of synchronised maturation of pluripotent stem cell-derived neural progenitor cells generates neurons which are characterised by a relatively hyperpolarized resting membrane potential, higher spontaneous and induced action potential activity, enhanced synaptic activity, more complete development of a mature inhibitory GABAA receptor phenotype and faster production of electrical network activity when compared to standard differentiation media. This entire process - from pre-patterned neural progenitor to active neuron - takes 3 weeks or less, making it an ideal platform for drug discovery and disease modelling in the fields of human neurodegenerative and neuropsychiatric disorders, such as Huntington's disease, Parkinson's disease, Alzheimer's disease or Schizophrenia.
This article is protected by copyright. All rights reserved
Publication date: November 2016
Source:Biomaterials, Volume 108
Author(s): Sarah E. Gilpin, Jonathan M. Charest, Xi Ren, Luis F. Tapias, Tong Wu, Daniele Evangelista-Leite, Douglas J. Mathisen, Harald C. Ott
Bio-engineered organs for transplantation may ultimately provide a personalized solution for end-stage organ failure, without the risk of rejection. Building upon the process of whole organ perfusion decellularization, we aimed to develop novel, translational methods for the recellularization and regeneration of transplantable lung constructs.We first isolated a proliferative KRT5+TP63+ basal epithelial stem cell population from human lung tissue and demonstrated expansion capacity in conventional 2D culture. We then repopulated acellular rat scaffolds in ex vivo whole organ culture and observed continued cell proliferation, in combination with primary pulmonary endothelial cells. To show clinical scalability, and to test the regenerative capacity of the basal cell population in a human context, we then recellularized and cultured isolated human lung scaffolds under biomimetic conditions. Analysis of the regenerated tissue constructs confirmed cell viability and sustained metabolic activity over 7 days of culture. Tissue analysis revealed extensive recellularization with organized tissue architecture and morphology, and preserved basal epithelial cell phenotype. The recellularized lung constructs displayed dynamic compliance and rudimentary gas exchange capacity. Our results underline the regenerative potential of patient-derived human airway stem cells in lung tissue engineering. We anticipate these advances to have clinically relevant implications for whole lung bioengineering and ex vivo organ repair.
Publication date: December 2016
Source:Journal of Environmental Radioactivity, Volume 165
Author(s): Hui Hu, Bangqiang Jiang, Huixiong Wu, Jubin Zhang, Xiaohui Chen
In this work, a biochar was prepared from bamboo (Acidosasa edulis) shoot shell through slow pyrolysis (under 300–700 °C). Characterization with various tools showed that the biochar surface was highly hydrophobic and also had more basic functional groups. Batch sorption experiments showed that the biochar had strong sorption ability to perrhenate (a chemical surrogate for pertechnetate) with maximum sorption capacity of 46.46 mg/g, which was significantly higher than commercial coconut shell activated carbon and some adsorbents reported previously. Desorption experiments showed that more than 94% of total perrhenate adsorbed could be recovered using 0.1 mol/L KOH as a desorption medium. Pearson correlation analysis showed that the recovery of perrhenate by the biochars was mainly through surface adsorption mechanisms involving both high hydrophobicity and high basic sites of biochar surface.
Due to unavoidable contaminations in feedstuff, pigs are easily exposed to aflatoxin B1 (AFB1) and suffer from poisoning, thus the poisoned products potentially affect human health. Heretofore, the metabolic process of AFB1 in pigs remains to be clarified, especially the principal cytochrome P450 oxidases responsible for its activation. In this study, we cloned CYP3A29 from pig liver and expressed it in Escherichia coli, and its activity has been confirmed with the typical P450 CO-reduced spectral characteristic and nifedipine-oxidizing activity. The reconstituted membrane incubation proved that the recombinant CYP3A29 was able to oxidize AFB1 to form AFB1-exo-8,9-epoxide in vitro. The structural basis for the regioselective epoxidation of AFB1 by CYP3A29 was further addressed. The T309A mutation significantly decreased the production of AFBO, whereas F304A exhibited an enhanced activation towards AFB1. In agreement with the mutagenesis study, the molecular docking simulation suggested that Thr309 played a significant role in stabilization of AFB1 binding in the active center through a hydrogen bond. In addition, the bulk phenyl group of Phe304 potentially imposed steric hindrance on the binding of AFB1. Our study demonstrates the bioactivation of pig CYP3A29 towards AFB1 in vitro, and provides the insight for understanding regioselectivity of CYP3A29 to AFB1.
http://ift.tt/2cGnq9f
2016-09-12T01-57-19Z
Source: Indo American Journal of Pharmaceutical Research
Ajit Kumar Mishra*, Neha Singh, Manju Kumari, Binita Kumari, Birendra Kumar, Divya Mishra.
In this work, we collected the three dimensional structure of Enterotoxin B which plays an important role in staphylococcus pathway. The protein structures were collected from PDB data bank. From the 3D structures of the proteins, the targeted derivatives were designed. Docking studies was performed with designed ligands from the drug. The drug derivatives docked to the protein by hydrogen boding interactions and these interactions play an important role in the binding studies. Docking results showed the best compounds among the derivatives.
http://ift.tt/2cSzzuV
2016-09-12T01-57-19Z
Source: Indo American Journal of Pharmaceutical Research
Dr. O. G. Bhusnure*, Shaikh Faisal Ekbal, Mane Jyoti, Sayyed Sarfaraz Ali, Hucche Bhimashankar, Surkute Ganesh.
Fast dissolving tablet format is designed to allow administration of an oral solid dose form in the absence of water or fluid intake. Such tablets readily dissolve or disintegrate in the saliva. Albendazole is anthalmentic agent which is used in disease like worms. As a vermicidal,albendazole causes degenerative alterations in the intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. It is a BCS class II drug. It exhibits poor bioavailability of about
http://ift.tt/2cSAqM6
2016-09-12T01-57-19Z
Source: Indo American Journal of Pharmaceutical Research
A. Suganthi*, A. Fathimunnisa, S. Sumithra and T.K. Ravi.
Buclizine hydrochloride from its tablet dosage form was estimated by developing a novel validated indirect spectrofluorimetric method. Here the Buclizine hydrochloride was derivatized into nitro compound using nitrating mixture with an aid of heat which showed good fluorescence in water at 446 nm after excited at 350 nm. The calibration graph showed linear over the range 200-1000 ng/ml. The assay of buclizine hydrochloride in marketed formulations was found to be 98.96 ± 0.1586. Recovery values were close to 100% with the % RSD values of 0.432% and 0.673% at 50% and 100% level respectively. From the results of validation it was observed that the method was found to be simple, accurate, sensitive and reproducible. Hence the proposed method can be used for routine quality control analysis.
http://ift.tt/2cCKabx
2016-09-12T01-57-19Z
Source: Indo American Journal of Pharmaceutical Research
Varun Chauhan, Gurjeet Kaur, Naveen, Kapil Goyal, Rakesh Sehgal.
E. granulosus responsible for causing Cystic echinococcosis (CE), a highly pathogenic infection, is causing considerable morbidity and mortality in humans. Fatty Acid Binding Proteins have been suggested to be promising vaccine candidates against several parasitic Platyhelminthes. The present study was thus aimed to identify HLA class I (HLA*A-02:01) restricted T cell epitopes, one of the most common occurring HLA Class I allele in human population, and B cell epitopes by screening of FABP-1 protein of E. granulosus using in-silico approach. The most promising predicted T cell epitopes were docked with HLA-*A 02:01 allele in order to ascertain the binding pattern of the identified peptides and HLA allele. The identified B and T cell epitopes were confirmed by visualizing there locations on the 3D model of FABP-1 protein. We believe that the present study will further help the researchers in better understanding the immune responses generated in an intermediate host in response to FABP protein of the parasite and may provide a platform to facilitate subunit vaccine design.
http://ift.tt/2cSyfIu